Bausch and Lomb Incorpoprated v Allergan Inc

Link copied
Case Copied 18 min read

official notice

decision of a delegate of the commissioner of patents

Application  :          No.675414 in the name of Bausch & Lomb Incorporated.

Title:          Method and Composition for Cleaning and Disinfecting Contact Lenses.

Action:          Application by Allergan Inc. for an extension of time under subsection 223(2) to file a notice of opposition.

Decision:          Issued            .

Abstract

Allergan’s attorney was watching for acceptance of this divisional application and received

verbal instructions to oppose it before acceptance.  The attorney’s interpretation of regulation 5.3(1) in conjunction with his failure to ensure he was reminded about the deadline for filing a notice of opposition resulted in him not complying with Allergan’s instructions.

The relative interests of the parties and the public interest do not favour either granting or refusing the extension of time.  Allergan considers there is no subject matter in either the parent or divisional application which is not of interest to it.  The decision on the opposition to the grant of a patent on the parent application has not been issued.  It seems more likely than not that Allergan is pursuing a serious opposition against the divisional application.  There was no undue delay.  Discretion exercised in Allergan’s favour and the time to file a notice of opposition extended.  Allergan given notice under regulation 22.14 about serving and filing the statement of grounds and particulars.

The finding that Allergan intended to file a notice of opposition depended on a statement made by attorney at the hearing.  The applicant did not say it would not have attended the hearing if this statement had been made earlier.  No award of costs.

patents act 1990

decision of a delegate of the commissioner of patents

Re:Application no.675414 by Bausch & Lomb Incorporated and an application by Allergan Inc. for an extension of time under subsection 223(2) to file a notice of opposition.

background

Application no.30439/92 by Bausch & Lomb Incorporated (Bausch) is a further application from application no.49989/90 (now no.628926).  The application was advertised as accepted under no.675414 on 6 February 1997 and thus any notice of any opposition was due to be filed by 6 May 1997.  On 6 May 1997 Alcon Laboratories Inc (Alcon) filed a notice of opposition to the grant of a patent on the application.

On 12 May 1997 Allergan Inc (Allergan) filed a notice of opposition to the grant of a patent on the application which was accompanied by an application for an extension of time under section 223(2).  Allergan filed a statutory declaration in support of its extension of time on 16 May 1997.

A copy of the application was sent to Bausch’s attorneys on 26 May 1997 and it objected to the extension of time.  The matter was set for hearing in Canberra on 16 July 1997 and both parties appeared by telephone.  Bausch was represented by Dr C Bodkin, patent attorney, of Spruson & Ferguson and Allergan was represented by Dr P Stearne, patent attorney, of Davies Collison Cave.  Mr J Siely, patent attorney, of Davies…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Bausch and Lomb Incorpoprated v Allergan Inc and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1997] APO 45
Decision Date

CaseChat Overview and Summary

Allergan Inc. applied for an extension of time to file a notice of opposition to a divisional patent application submitted by Bausch & Lomb Incorporated. The application in question was accepted on 6 February 1997, and the deadline for filing a notice of opposition was 6 May 1997. Allergan, however, missed this deadline due to an error or omission in the office of their Australian attorneys, leading to their application for an extension of time. The key legal issue the court had to decide was whether the delegate of the Commissioner of Patents should exercise their discretion under subsection 223(2) of the Patents Act 1990 to extend the time for Allergan to file a notice of opposition.

In reaching its decision, the court considered the nature of the error or omission, the intent of Allergan to oppose the application, the relative interests of the parties and the public, and whether there was undue delay in filing the application for extension of time. The court found that Allergan intended to oppose the application based on a statement made by their patent attorney at the hearing. It also found that the relative interests of the parties and the public interest did not favour either granting or refusing the extension of time. The court concluded that there was no undue delay, as the period of delay was approximately two months.

The court exercised its discretion in favour of Allergan and granted the extension of time, allowing Allergan until 12 May 1997 to file a notice of opposition. The court also gave Allergan notice under regulation 22.14 about serving and filing a statement of grounds and particulars. The court decided not to award costs to either party, as it found that Bausch & Lomb's objection to the extension of time was not frivolous.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established